Neuronetics
STIM
69 hedge funds and large institutions have $38.6M invested in Neuronetics in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 30 reducing their positions, and 12 closing their positions.
175% more call options, than puts
Call options by funds: $22K | Put options by funds: $8K
2.03% less ownership
Funds ownership: 65% → 62.97% (-2%)
7% less funds holding
Funds holding: 74 → 69 (-5)
28% less capital invested
Capital invested by funds: $53.6M → $38.6M (-$15.1M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
53% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.76M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$905K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$485K |
| 4 |
SAM
Silvercrest Asset Management
New York
|
+$387K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$902K |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$871K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$592K |
| 4 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$453K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$353K |
STIM Hedge Fund Activity: Q2 2023 in Review
69 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2023, worth a combined $38.6M — down 28% from $53.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of STIM and 7 opened new positions — a net loss of 5 holders — while 30 trimmed existing stakes and 14 added.
The largest buyer was Archon Capital Management, adding an estimated $1.76M. The largest seller was Hussman Strategic Advisors, exiting entirely with an estimated $902K sold.
- 69 institutional investors held Neuronetics (STIM) as of Q2 2023, down from 74 in Q1 2023.
- Funds reported $38.6M of Neuronetics stock for Q2 2023, down 28% quarter-over-quarter.
- 7 funds opened new Neuronetics positions in Q2 2023 and 12 closed out, a net change of -5 holders.
- The largest Neuronetics buyer in Q2 2023 was Archon Capital Management, an estimated $1.76M added.
- The largest Neuronetics seller in Q2 2023 was Hussman Strategic Advisors, an estimated $902K sold.
Based on aggregated 13F filings for Q2 2023.